Deniz Tataroglu Ozyukseler
7PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 17, 2022
Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study.Tuğba Başoğlu, Abdullah Sakin, Cihan Erol
|May 11, 2022
Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?Özgecan Dülgar, Başak Bala Öven, Muhammed Mustafa Atcı
|Jan 17, 2022
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer.Seval Ay, Muhammed Mustafa Atcı, Rukiye Arıkan
|May 07, 2021
Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?Murat Ayhan, Şahin Laçin, Deniz T Özyükseler
|Aug 28, 2020
Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer.Özlem Ercelep, Deniz Tataroğlu, Melike Özçelik
|Aug 28, 2020
Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?Özgecan Dülgar, Deniz Tataroğlu Özyükseler, Mustafa Başak
Pageof 2
Frequent Collaborators
4 joint publications
Seval Ay
4 joint publications
Özgecan Dülgar
3 joint publications
Mahmut Gümüş
2 joint publications
Başak Bala Öven
2 joint publications
Rukiye Arıkan
2 joint publications
Muhammed Mustafa Atcı
1 joint publications
Özlem Ercelep
1 joint publications
Melike Özçelik
1 joint publications
Perran Fulden Yumuk
1 joint publications
Mustafa Değirmenci
